ProfileGDS4718 / 215775_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 28% 40% 51% 37% 34% 38% 46% 35% 35% 37% 34% 38% 48% 35% 37% 32% 35% 41% 34% 27% 42% 39% 33% 35% 41% 39% 38% 34% 35% 37% 31% 35% 36% 32% 32% 41% 32% 35% 38% 39% 32% 30% 39% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4818428
GSM549102patient 115, normal, homogenized [OPG study]5.0316240
GSM549104patient 119, normal, homogenized [OPG study]5.5762851
GSM549108patient 138, normal, homogenized [OPG study]4.882237
GSM549119patient 077, normal, homogenized [OPG study]4.7400934
GSM549133patient 032, cancer, homogenized [OPG study]4.8411238
GSM549139patient 042, cancer, homogenized [OPG study]5.2612146
GSM549099patient 107, normal, homogenized [OPG study]4.7779835
GSM549109patient 139, normal, homogenized [OPG study]4.7759835
GSM549110patient 046, normal, homogenized [OPG study]4.8724237
GSM549114patient 063, normal, homogenized [OPG study]4.6643834
GSM549122patient 082, normal, homogenized [OPG study]4.8965938
GSM549134patient 033, cancer, homogenized [OPG study]5.3977848
GSM549136patient 036, cancer, homogenized [OPG study]4.677235
GSM549140patient 044, cancer, homogenized [OPG study]4.8016437
GSM549111patient 047, normal, homogenized [OPG study]4.6158132
GSM549113patient 057, normal, homogenized [OPG study]4.6824235
GSM549132patient 031, cancer, homogenized [OPG study]5.0020841
GSM549137patient 038, cancer, homogenized [OPG study]4.7026834
GSM549142patient 047, cancer, homogenized [OPG study]4.5160927
GSM549100patient 110, normal, homogenized [OPG study]5.1324642
GSM549107patient 135, normal, homogenized [OPG study]4.9056239
GSM549115patient 068, normal, homogenized [OPG study]4.6234433
GSM549116patient 072, normal, homogenized [OPG study]4.7285735
GSM549120patient 078, normal, homogenized [OPG study]5.02841
GSM549131patient 030, cancer, homogenized [OPG study]4.8879139
GSM549118patient 074, normal, homogenized [OPG study]4.9137138
GSM549129patient 027, cancer, homogenized [OPG study]4.7434834
GSM549123patient 088, normal, homogenized [OPG study]4.757835
GSM549124patient 006, cancer, homogenized [OPG study]4.8919237
GSM549126patient 015, cancer, homogenized [OPG study]4.5607731
GSM549128patient 025, cancer, homogenized [OPG study]4.7581535
GSM549103patient 117, normal, homogenized [OPG study]4.8755936
GSM549117patient 073, normal, homogenized [OPG study]4.6169132
GSM549138patient 041, cancer, homogenized [OPG study]4.598432
GSM549141patient 045, cancer, homogenized [OPG study]4.9928741
GSM549130patient 028, cancer, homogenized [OPG study]4.6397332
GSM549101patient 111, normal, homogenized [OPG study]4.7787435
GSM549105patient 128, normal, homogenized [OPG study]4.9235738
GSM549106patient 134, normal, homogenized [OPG study]4.9035839
GSM549112patient 048, normal, homogenized [OPG study]4.631832
GSM549125patient 011, cancer, homogenized [OPG study]4.5734930
GSM549127patient 024, cancer, homogenized [OPG study]4.932639
GSM549135patient 035, cancer, homogenized [OPG study]4.710935